These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 22710695
1. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis. Seeherunvong W, Abitbol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M. Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695 [Abstract] [Full Text] [Related]
2. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J. Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134 [Abstract] [Full Text] [Related]
3. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients. Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Muftuoglu T, Kirilmaz A. Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798 [Abstract] [Full Text] [Related]
4. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation. Eser B, Yayar O, Buyukbakkal M, Erdogan B, Ercan Z, Merhametsiz O, Haspulat A, Oğuz EG, Dogan İ, Canbakan B, Ayli MD. Nefrologia; 2015 Jul; 35(5):465-72. PubMed ID: 26394828 [Abstract] [Full Text] [Related]
5. FGF23 and Left Ventricular Hypertrophy in Children with CKD. Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA. Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789 [Abstract] [Full Text] [Related]
6. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Circulation; 2009 May 19; 119(19):2545-52. PubMed ID: 19414634 [Abstract] [Full Text] [Related]
7. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants. Zhao X, Zhu L, Jin W, Yang B, Wang Y, Ni M, Zhao Y, Gan L, Zuo L. BMC Cardiovasc Disord; 2022 Feb 16; 22(1):55. PubMed ID: 35172749 [Abstract] [Full Text] [Related]
8. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis. Knap B, Večerić-Haler Ž, Benedik M, Buturović-Ponikvar J, Ponikvar R, Bren AF. Ther Apher Dial; 2013 Aug 16; 17(4):407-11. PubMed ID: 23931880 [Abstract] [Full Text] [Related]
9. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease. Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM. Pediatr Nephrol; 2015 Oct 16; 30(10):1843-52. PubMed ID: 25975437 [Abstract] [Full Text] [Related]
10. Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study. Kovács A, Tapolyai M, Celeng C, Gara E, Faludi M, Berta K, Apor A, Nagy A, Tislér A, Merkely B. Int J Cardiovasc Imaging; 2014 Oct 16; 30(7):1331-7. PubMed ID: 25001896 [Abstract] [Full Text] [Related]
11. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE. Atherosclerosis; 2009 Dec 16; 207(2):546-51. PubMed ID: 19524924 [Abstract] [Full Text] [Related]
13. Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease. Unsal A, Kose Budak S, Koc Y, Basturk T, Sakaci T, Ahbap E, Sinangil A. Kidney Blood Press Res; 2012 Dec 16; 36(1):55-64. PubMed ID: 22854270 [Abstract] [Full Text] [Related]
15. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients. Sarmento-Dias M, Santos-Araújo C, Poínhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M. Clin Nephrol; 2016 Mar 16; 85(3):135-41. PubMed ID: 26833300 [Abstract] [Full Text] [Related]
16. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction. Nielsen TL, Plesner LL, Warming PE, Mortensen OH, Iversen KK, Heaf JG. Nefrologia (Engl Ed); 2019 Mar 16; 39(3):258-268. PubMed ID: 30723045 [Abstract] [Full Text] [Related]
18. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study. Brady TM, Roem J, Cox C, Schneider MF, Wilson AC, Furth SL, Warady BA, Mitsnefes M. Am J Kidney Dis; 2020 Aug 16; 76(2):166-173. PubMed ID: 32389356 [Abstract] [Full Text] [Related]
19. Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD. Pediatr Cardiol; 2013 Mar 16; 34(3):536-42. PubMed ID: 22941497 [Abstract] [Full Text] [Related]
20. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T. Negishi K, Kobayashi M, Ochiai I, Yamazaki Y, Hasegawa H, Yamashita T, Shimizu T, Kasama S, Kurabayashi M. Circ J; 2010 Nov 16; 74(12):2734-40. PubMed ID: 21041973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]